- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03731936
Artificial Intelligence to Assess the Association Between Facial Characteristics and Coronary Artery Diseases
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Several age-related appearance factors were described associated with increased risk of coronary artery diseases (CAD). However, several limitations made these facial risk factors hard to be utilized in clinical practice, including 1) low prevalence in CAD patients, 2) lack of specific definition, 3) poor reproducibility in artificial recognition.
Thus, the investigators designed a multi-center, cross-sectional study to explore the association between facial characteristics and CAD and evaluate the diagnostic efficacy of appearance factors for CAD. The investigators will recruit patients undergoing coronary angiography or coronary computer tomography angiography. Patients' baseline information and facial images will be collected. First, the investigators will explore the facial factors associated with CAD by using artificial intelligence technology to compare facial photographs between patients with CAD and without CAD. Secondary, the investigators will evaluate the dose-response relationship between facial characteristics and CAD. Third, the investigators will establish a CAD risk model based on facial factors, and evaluate the diagnostic effect of the model.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Beijing
-
Beijing, Beijing, Porcelana, 100032
- Fuwai Hospital
-
Beijing, Beijing, Porcelana, 100032
- Beijing Anzhen Hospital
-
Beijing, Beijing, Porcelana, 100032
- Guanganmen Hospital, Chinese Academy of Traditional Chinese Medicine
-
-
Hubei
-
Wuhan, Hubei, Porcelana, 430000
- Wuhan Union Hospital
-
-
Jiangsu
-
Xuzhou, Jiangsu, Porcelana, 221000
- Xuzhou Third People's Hospital
-
-
Liangning
-
Dalian, Liangning, Porcelana, 116000
- The First Affiliated Hospital of Dalian Medical University
-
-
Shanghai
-
Shanghai, Shanghai, Porcelana, 200000
- Shanghai East Hospital
-
Shanghai, Shanghai, Porcelana, 200000
- Shanghai Renji Hospital
-
-
Zhejiang
-
Wenzhou, Zhejiang, Porcelana, 325000
- The fisrt affiliated hospital of Wenzhou medical university
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Undergoing coronary angiography or coronary computer tomography angiography
- Written informed consent
Exclusion Criteria:
- Prior percutaneous coronary intervention (PCI)
- Prior coronary artery bypass graft (CABG)
- Screening coronary artery disease before treating other heart diseases
- Without blood biochemistry outcome
- With artificially facial alteration (i.e. cosmetic surgery, facial trauma or make-up)
- Other situations which make patients fail to be photographed
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Model establishment and test group
Patients undergoing coronary angiography or coronary computer tomography angiography will be enrolled.
Patients data will be used to establish the facial based diagnostic model of coronary artery diseases, and to prospectively validate the diagnostic effectiveness of the model.
|
Sin intervención
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sensitivity of diagnostic model
Periodo de tiempo: at the end of enrollment (6 months)
|
The sensitivity of coronary artery diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Specificity of diagnostic model
Periodo de tiempo: at the end of enrollment (6 months)
|
The specificity of coronary artery diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
|
Specificity of diagnostic model
Periodo de tiempo: at the end of enrollment (6 months)
|
Area under receiver operating curve (AUC) of diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
|
Positive predictive value (PPV)
Periodo de tiempo: at the end of enrollment (6 months)
|
PPV of diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
|
Negative predictive value (NPV)
Periodo de tiempo: at the end of enrollment (6 months)
|
NPV of diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
|
Diagnostic accuracy rate
Periodo de tiempo: at the end of enrollment (6 months)
|
Diagnostic accuracy rate of diagnostic model assessed in model test group
|
at the end of enrollment (6 months)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 20181104-2017-907
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .